Pennington Biomedical Research Center, Exercise Biology Laboratory, Baton Rouge 70808, USA.
Int J Sports Med. 2011 Nov;32(11):882-8. doi: 10.1055/s-0031-1280779. Epub 2011 Oct 7.
We examined the effect of Astaxanthin (AST) on substrate metabolism and cycling time trial (TT) performance by randomly assigning 21 competitive cyclists to 28 d of encapsulated AST (4 mg/d) or placebo (PLA) supplementation. Testing included a VO2max test and on a separate day a 2 h constant intensity pre-exhaustion ride, after a 10 h fast, at 5% below VO2max stimulated onset of 4 mmol/L lactic acid followed 5 min later by a 20 km TT. Analysis included ANOVA and post-hoc testing. Data are Mean (SD) and (95% CI) when expressed as change (pre vs. post). Fourteen participants successfully completed the trial. Overall, we observed significant improvements in 20 km TT performance in the AST group (n=7; -121 s; 95% CI, -185, -53), but not the PLA (n=7; -19 s; 95% CI, -84, 45). The AST group was significantly different vs. PLA (P<0.05). The AST group significantly increased power output (20 W; 95% CI, 1, 38), while the PLA group did not (1.6 W; 95% CI, -17, 20). The mechanism of action for these improvements remains unclear, as we observed no treatment effects for carbohydrate and fat oxidation, or blood indices indicative of fuel mobilization. While AST significantly improved TT performance the mechanism of action explaining this effect remains obscure.
我们将 21 名竞技自行车手随机分配到 28 天的封装虾青素(AST)或安慰剂(PLA)补充剂中,研究 AST 对基质代谢和计时赛(TT)性能的影响。测试包括最大摄氧量测试和在单独的一天,进行 2 小时的恒定强度预疲劳骑行,禁食 10 小时后,以 5%低于最大摄氧量刺激 4mmol/L 乳酸的起始值,5 分钟后进行 20km TT。分析包括 ANOVA 和事后测试。数据以平均值(SD)和(95%CI)表示,当表示为变化(前与后)时。有 14 名参与者成功完成了试验。总体而言,我们观察到 AST 组 20km TT 性能有显著提高(n=7;-121s;95%CI,-185,-53),但 PLA 组(n=7;-19s;95%CI,-84,45)没有。AST 组与 PLA 组有显著差异(P<0.05)。AST 组的功率输出显著增加(20W;95%CI,1,38),而 PLA 组没有(1.6W;95%CI,-17,20)。这些改善的作用机制尚不清楚,因为我们没有观察到碳水化合物和脂肪氧化或血液指标的治疗效果,这些指标表明燃料动员。虽然 AST 显著提高了 TT 性能,但解释这种效果的作用机制仍然不清楚。